TW200621785A - Analgesic - Google Patents
AnalgesicInfo
- Publication number
- TW200621785A TW200621785A TW094138512A TW94138512A TW200621785A TW 200621785 A TW200621785 A TW 200621785A TW 094138512 A TW094138512 A TW 094138512A TW 94138512 A TW94138512 A TW 94138512A TW 200621785 A TW200621785 A TW 200621785A
- Authority
- TW
- Taiwan
- Prior art keywords
- provides
- analgesic
- present
- various
- subsitituent
- Prior art date
Links
- 230000000202 analgesic effect Effects 0.000 title abstract 2
- 208000002193 Pain Diseases 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 239000000654 additive Substances 0.000 abstract 1
- 230000000996 additive effect Effects 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 150000003809 morphinane derivatives Chemical class 0.000 abstract 1
- 230000036407 pain Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
- C07D489/06—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with a hetero atom directly attached in position 14
- C07D489/08—Oxygen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Emergency Medicine (AREA)
- Epidemiology (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2004320583 | 2004-11-04 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| TW200621785A true TW200621785A (en) | 2006-07-01 |
| TWI356826B TWI356826B (cg-RX-API-DMAC7.html) | 2012-01-21 |
Family
ID=36319248
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW094138512A TW200621785A (en) | 2004-11-04 | 2005-11-03 | Analgesic |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US8470845B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1820505A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP4706636B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR101285645B1 (cg-RX-API-DMAC7.html) |
| CN (1) | CN101090722B (cg-RX-API-DMAC7.html) |
| AR (1) | AR053098A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2586181C (cg-RX-API-DMAC7.html) |
| MX (1) | MX2007005336A (cg-RX-API-DMAC7.html) |
| NO (1) | NO20072832L (cg-RX-API-DMAC7.html) |
| PE (1) | PE20060723A1 (cg-RX-API-DMAC7.html) |
| TW (1) | TW200621785A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2006049248A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5119925B2 (ja) | 2005-11-09 | 2013-01-16 | 東レ株式会社 | 機能性腸障害の治療または予防剤 |
| CA2634055C (en) * | 2005-12-21 | 2011-07-05 | Toray Industries, Inc. | Antitussive agent |
| FR2902341B1 (fr) | 2006-06-16 | 2011-02-25 | Scras | Utilisation therapeutique simultanee, separee ou etalee dans le temps d'au moins une neurotoxine botulique, et d'au moins un derive opiace |
| FR2910327B1 (fr) | 2006-12-22 | 2013-04-26 | Scras | Utilisation d'au moins une neurotoxine botulique pour traiter la douleur induite par les traitements therapeutiques du virus du sida. |
| KR101546398B1 (ko) * | 2007-05-21 | 2015-08-26 | 도레이 카부시키가이샤 | 결정성 미분화 입자 |
| KR101510799B1 (ko) * | 2007-05-21 | 2015-04-10 | 도레이 카부시키가이샤 | 의약 정제의 제조법 |
| CN101848713B (zh) * | 2007-05-21 | 2012-04-11 | 东丽株式会社 | 含有特定的有机酸的口服制剂以及口服制剂的溶出性和化学稳定性的改善方法 |
| FR2930447B1 (fr) | 2008-04-25 | 2010-07-30 | Sod Conseils Rech Applic | Utilisation therapeutique d'au moins une neurotoxine botulique dans le traitement de la douleur dans le cas de la neuropathie diabetique |
| HUE069820T2 (hu) | 2018-03-08 | 2025-04-28 | Victoria Link Ltd | Nalfurafin alkalmazása demielinizációs betegségek kezelésére |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS4118823B1 (cg-RX-API-DMAC7.html) * | 1964-02-03 | 1966-10-31 | ||
| US3318886A (en) * | 1965-07-21 | 1967-05-09 | American Cyanamid Co | Substituted 7-hydroxymethyl-7, 8-dihydro-6-amino-6, 14-endoethenocodides and morphide |
| NL8102558A (nl) * | 1981-05-25 | 1982-12-16 | Alcoa Nederland Bv | Lichtmast met versterking van de opening in het onderste gedeelte. |
| JP2525552B2 (ja) * | 1992-01-23 | 1996-08-21 | 東レ株式会社 | モルヒナン誘導体および医薬用途 |
| DE69424853T2 (de) | 1993-07-23 | 2000-10-05 | Toray Industries, Inc. | Morphinan-derivate und ihre medizinische verwendung |
| ATE259232T1 (de) | 1995-03-03 | 2004-02-15 | Endo Pharmaceuticals Inc | Verwendung von dextromethorphan oder dextrorphan zur behandlung der harninkontinenz |
| CN1374963A (zh) | 1999-07-19 | 2002-10-16 | 东丽株式会社 | 尿频或尿失禁的治疗或预防剂 |
| DE19939044A1 (de) * | 1999-08-18 | 2001-03-15 | Gruenenthal Gmbh | Verwendung von Morphinanderivaten als Arzneimittel |
| DE60133584T2 (de) * | 2000-10-31 | 2009-06-04 | Rensselaer Polytechnic Institute | 4-arylpiperidine als opioidrezeptorbindende agenzien |
| EP1555266B1 (en) | 2002-10-09 | 2014-05-21 | Toray Industries, Inc. | Remedies or preventives for urinary incontinence and morphinan derivatives having nitrogen-containing heterocyclic group |
| JP4118824B2 (ja) | 2004-02-24 | 2008-07-16 | 株式会社日立製作所 | 優先パケットの遅延を最小化するシェーピング装置 |
| JP4118826B2 (ja) | 2004-03-01 | 2008-07-16 | リオン株式会社 | 補聴器用ケースなどの製造方法及びその装置 |
| US7718664B2 (en) | 2004-03-30 | 2010-05-18 | Toray Industries, Inc. | Anti-itching agent |
-
2005
- 2005-11-03 TW TW094138512A patent/TW200621785A/zh not_active IP Right Cessation
- 2005-11-03 AR ARP050104603A patent/AR053098A1/es not_active Application Discontinuation
- 2005-11-03 PE PE2005001291A patent/PE20060723A1/es not_active Application Discontinuation
- 2005-11-04 MX MX2007005336A patent/MX2007005336A/es active IP Right Grant
- 2005-11-04 CN CN200580045038XA patent/CN101090722B/zh not_active Expired - Fee Related
- 2005-11-04 EP EP05799891A patent/EP1820505A4/en not_active Withdrawn
- 2005-11-04 CA CA2586181A patent/CA2586181C/en not_active Expired - Fee Related
- 2005-11-04 US US11/667,136 patent/US8470845B2/en not_active Expired - Fee Related
- 2005-11-04 JP JP2006542444A patent/JP4706636B2/ja not_active Expired - Fee Related
- 2005-11-04 WO PCT/JP2005/020297 patent/WO2006049248A1/ja not_active Ceased
- 2005-11-04 KR KR1020077011752A patent/KR101285645B1/ko not_active Expired - Fee Related
-
2007
- 2007-06-04 NO NO20072832A patent/NO20072832L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| US20070299100A1 (en) | 2007-12-27 |
| TWI356826B (cg-RX-API-DMAC7.html) | 2012-01-21 |
| JP4706636B2 (ja) | 2011-06-22 |
| WO2006049248A1 (ja) | 2006-05-11 |
| US8470845B2 (en) | 2013-06-25 |
| CA2586181C (en) | 2012-11-27 |
| MX2007005336A (es) | 2007-06-25 |
| EP1820505A1 (en) | 2007-08-22 |
| EP1820505A4 (en) | 2010-01-20 |
| JPWO2006049248A1 (ja) | 2008-08-07 |
| CN101090722A (zh) | 2007-12-19 |
| KR20070085436A (ko) | 2007-08-27 |
| HK1115808A1 (en) | 2008-12-12 |
| CA2586181A1 (en) | 2006-05-11 |
| PE20060723A1 (es) | 2006-08-29 |
| CN101090722B (zh) | 2011-12-21 |
| NO20072832L (no) | 2007-08-01 |
| KR101285645B1 (ko) | 2013-07-12 |
| AR053098A1 (es) | 2007-04-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW200615266A (en) | Organic compounds | |
| UA84712C2 (en) | N-substituted pyrazolyl-amidyl-benzimidazolyl c-kit inhibitors | |
| TW200728307A (en) | Novel spirochromanone derivatives | |
| PH12014502721A1 (en) | IMIDAZO[1,2-b] PYRIDAZINE DERIVATIVES AS KINASE INHIBITORS | |
| MY140638A (en) | New heterocyclic compounds, which are active as inhibitors of beta-lactamases | |
| TW200740776A (en) | N-phenylbenzotriazolyl c-kit inhibitors | |
| EA200501936A1 (ru) | Производные пиридо[2,1-a]изохинолина в качестве ингибиторов dpp-iv | |
| WO2005110410A3 (en) | Kinase inhibitors as therapeutic agents | |
| WO2005075425A3 (en) | Substituted bisarylurea derivatives as kinase inhibitors | |
| IL157254A0 (en) | N-substituted nonaryl-heterocyclic nmda/mr2b antagonists | |
| TW200612958A (en) | Substituted imidazole derivatives | |
| MX2010008818A (es) | Derivado de bicicloamina. | |
| UA83875C2 (ru) | Производные хинолина для применения в качестве микобактериальных ингибиторов | |
| WO2005021544A3 (en) | N3-substituted imidazopyridine-derivatives as c-kit inhibitors | |
| MX2009008779A (es) | Composicion farmacéutica que comprende derivado de pirazina y método para usar el derivado de pirazina en combinación. | |
| MXPA06009475A (es) | Derivados de quinazolina y usos terapeuticos de los mismos. | |
| TW200736229A (en) | Substituted 1H-benzimidazole-4-carboxamides are potent PARP inhibitors | |
| NO20080033L (no) | Kinolinderivater som NK3-antagonister | |
| MXPA05013151A (es) | 3-fluoro-piperidinas como antagonistas de n-metil-d-aspartato/nr2b. | |
| NO20072832L (no) | Smertestillende middel | |
| UA97348C2 (en) | HETEROCYCLIC NF-kB INHIBITORS | |
| TW200800951A (en) | Substituted imidazole compounds as KSP inhibitors | |
| EP1736157A4 (en) | MEDIUM AGAINST JUCKREIZ | |
| TW200628153A (en) | Novel compounds | |
| MXPA04009421A (es) | Compuestos de tiazol-2-ilimina como inhibidores de la pde-7. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | Annulment or lapse of patent due to non-payment of fees |